Phase 1 Depression and Anxiety Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 18 and 65 years of age
- People who are right-handed
- For the healthy volunteer (control) group: People who do not have major depression, confirmed by scoring 7 or below on a standard depression rating scale, and who have no personal history of depression based on reported history and medical records
- For the treatment-resistant depression group: People who have major depression confirmed by scoring 17 or above on a standard depression rating scale, and whose medical records show that at least 3 to 4 antidepressant treatments at adequate doses and durations have not worked, including at least one treatment during the current depressive episode
- People with a good command of the English language
Who may not be able to join:
- People who have been diagnosed with another significant mental health condition (other than major depression for the depression group), as confirmed by medical records and a structured clinical interview
- People with known neurological or serious medical conditions, including dementia, stroke, brain injury, Parkinson's disease, brain tumors, multiple sclerosis, seizure disorders, or severe heart or lung disease
- People currently taking any medication that acts on the central nervous system, as assessed by the study investigator
- People with a known condition that affects how the body processes or removes drugs, such as kidney or liver disease, as assessed by the study investigator
- People who are left-handed
- People who are not suitable for MRI scans, for example due to a history of claustrophobia or having metal implants in the body (as determined by an MRI screening tool)
- For the control group only: People currently using any psychiatric medications, antidepressants, or prescription or non-prescription drugs or herbal products intended to treat depression or anxiety
- People with a history of substance dependence or misuse within the past 12 months, based on reported history or a urine drug screen
- People who are able to become pregnant and are not using effective contraception
- People for whom nitrous oxide (the study drug) would be medically unsuitable, including those with: a collapsed lung (pneumothorax), a bowel obstruction, a blockage in the middle ear, raised pressure in the skull, a chronic deficiency in vitamin B12 or folate being treated with supplements, current pregnancy, or those who are breastfeeding
- People who are not able to provide informed consent
- People who, in the investigators' judgment, may face safety risks or difficulties participating for any other reason — for example, living more than 100 miles from the clinic
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Charles R Conway, MD, Washington University School of Medicine
Phone: 314-362-2463
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Comparison of functional connectivity between default mode network of treatment-resistant depressed and non-depressed participants; Comparison of functional connectivity between affective network of treatment-resistant depressed and non-depressed participants; Comparison of functional connectivity between cognitive control network of treatment-resistant depressed and non-depressed participants; Comparison of functional connectivity between dorsal nexus of treatment-resistant depressed and non-depressed participants
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.